{"transactions":[{"id":802606,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-22T20:26:41.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":24367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":321692,"source":{"system":"sec-edgar","filing":"0000905148-26-001781","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826001781/form4.xml","form_type":"4"}},{"id":950606,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-01-05T21:21:13.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":42507,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted shares of common stock in lieu of cash for board services for 2026. The number of shares was determined by dividing (A) the aggregate amount of the retainer to be earned for board services for such period, by (B) the average fair market value of a share of common stock the day prior to the grant date (rounded down to the nearest whole share). The average fair market value was $1.99 per share, the average of the high and low price of the common stock, the day prior to the grant date."}],"balance_after":297325,"source":{"system":"sec-edgar","filing":"0000905148-26-000027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514826000027/form4.xml","form_type":"4"}},{"id":1054414,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-08-27T20:13:53.000Z","date":"2025-08-25","kind":"grant","planned":false,"acquired":true,"shares":86956,"price":1.15,"value":99999.4,"ownership":{"direct":true},"balance_after":254818,"source":{"system":"sec-edgar","filing":"0000905148-25-003151","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825003151/form4.xml","form_type":"4"}},{"id":1160919,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-02T21:02:07.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":79592,"derivative":{"exercise_price":0.95,"expiration_date":"2035-04-29","underlying":"Common Stock","underlying_shares":79592},"source":{"system":"sec-edgar","filing":"0000905148-25-001424","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001424/form4.xml","form_type":"4"}},{"id":1160918,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-02T21:02:07.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":79504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":167862,"source":{"system":"sec-edgar","filing":"0000905148-25-001424","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514825001424/form4.xml","form_type":"4"}},{"id":1480377,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T21:23:21.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":35181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":35181,"derivative":{"exercise_price":1.72,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":35181},"source":{"system":"sec-edgar","filing":"0000905148-24-001709","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514824001709/form4.xml","form_type":"4"}},{"id":1480376,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-13T21:23:21.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":41143,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":88358,"source":{"system":"sec-edgar","filing":"0000905148-24-001709","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000090514824001709/form4.xml","form_type":"4"}},{"id":1862002,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Stock Option","published_at":"2023-06-08T22:49:07.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":9639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":9639,"derivative":{"exercise_price":3.83,"expiration_date":"2033-06-05","underlying":"Common Stock","underlying_shares":9639},"source":{"system":"sec-edgar","filing":"0001140361-23-029024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123029024/form4.xml","form_type":"4"}},{"id":1862001,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-08T22:49:07.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":10976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units which vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":47215,"source":{"system":"sec-edgar","filing":"0001140361-23-029024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123029024/form4.xml","form_type":"4"}},{"id":2015659,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-14T19:03:25.000Z","date":"2022-12-27","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":36239,"source":{"system":"sec-edgar","filing":"0001140361-23-006838","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036123006838/form5.xml","form_type":"5"}},{"id":2134100,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Series B Warrant (right to buy)","published_at":"2022-10-20T20:01:44.000Z","date":"2022-10-19","kind":"other","acquired":false,"shares":1574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The expiration date of the Series B Warrants occurred on the later of (x) the Reservation Date (as defined in the Series B Warrants) and (y) the date on which the Series B Warrants were exercised in full."}],"balance_after":0,"derivative":{"exercise_price":0.0001,"exercise_date":"2020-11-19","expiration_date":"2022-10-20","underlying":"Common Stock","underlying_shares":1574},"source":{"system":"sec-edgar","filing":"0001140361-22-037954","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122037954/form4.xml","form_type":"4"}},{"id":2134099,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-10-20T20:01:44.000Z","date":"2022-10-19","kind":"other","acquired":true,"shares":1574,"price":0.0001,"value":0.1574,"ownership":{"direct":true},"balance_after":41239,"source":{"system":"sec-edgar","filing":"0001140361-22-037954","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122037954/form4.xml","form_type":"4"}},{"id":2231284,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-06-15T20:01:26.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":1.93,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-22-023047","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122023047/form4.xml","form_type":"4"}},{"id":2397541,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-02-14T14:17:19.000Z","date":"2021-12-23","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39665,"source":{"system":"sec-edgar","filing":"0001140361-22-005102","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036122005102/form5.xml","form_type":"5"}},{"id":2675364,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-06-09T22:22:07.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to the Reporting Person's continuing service through the vesting date."}],"balance_after":20000,"derivative":{"exercise_price":5.74,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-21-020426","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036121020426/form4.xml","form_type":"4"}},{"id":2965938,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Series B Warrant (right to buy)","published_at":"2020-11-26T00:27:07.000Z","date":"2020-11-19","kind":"purchase","acquired":true,"shares":1574,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to adjustment based on certain price reset provisions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $50,000."}],"balance_after":1574,"derivative":{"exercise_price":0.0001,"exercise_date":"2020-11-19","expiration_date":"2022-01-28","underlying":"Common Stock","underlying_shares":1574},"source":{"system":"sec-edgar","filing":"0001140361-20-026647","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036120026647/form4.xml","form_type":"4"}},{"id":2965937,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Series A Warrant (right to buy)","published_at":"2020-11-26T00:27:07.000Z","date":"2020-11-19","kind":"purchase","acquired":true,"shares":13394,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Subject to adjustment based on certain price reset provisions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $50,000."}],"balance_after":13394,"derivative":{"exercise_price":4.4795,"exercise_date":"2020-11-19","expiration_date":"2025-11-19","underlying":"Common Stock","underlying_shares":13394},"source":{"system":"sec-edgar","filing":"0001140361-20-026647","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036120026647/form4.xml","form_type":"4"}},{"id":2965936,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-26T00:27:07.000Z","date":"2020-11-19","kind":"purchase","acquired":true,"shares":8865,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $50,000."}],"balance_after":44665,"source":{"system":"sec-edgar","filing":"0001140361-20-026647","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036120026647/form4.xml","form_type":"4"}},{"id":2980859,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2020-11-13T22:27:29.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting in 12 equal monthly increments beginning on November 30, 2020, except for October 31, 2021 when the balance vests."}],"balance_after":5000,"derivative":{"exercise_price":4.05,"expiration_date":"2030-11-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001140361-20-025551","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000114036120025551/form4.xml","form_type":"4"}},{"id":2988088,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-09T23:08:57.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":52825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired the shares and options to acquire shares of the common stock of Rexahn Pharmaceuticals, Inc. (\"Rexahn\") on November 5, 2020, in exchange for shares and options to acquire shares of the common stock of Ocuphire Pharma, Inc. (\"Ocuphire\"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of June 17, 2020, as amended, between Rexahn, Razor Merger Sub, Inc., and Ocuphire pursuant to which Ocuphire became a wholly-owned subsidiary of Rexahn. Per the terms of the Merger Agreement, each share of Ocuphire common stock was converted into the right to receive 1.0565 shares of Rexahn common stock. Subsequent to the merger, the name of the issuer was changed from Rexahn Pharmaceuticals, Inc. to Ocuphire Pharma, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"5,282 shares vested on December 31, 2019, and the remaining shares vest in equal monthly installments from January 2020 through December 2022 subject to continued service."}],"balance_after":52825,"derivative":{"exercise_price":1.21,"expiration_date":"2029-12-27","underlying":"Common Stock","underlying_shares":52825},"source":{"system":"sec-edgar","filing":"0001596771-20-000111","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000159677120000111/primary_doc.xml","form_type":"4"}},{"id":2988087,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-09T23:08:57.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":35663,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired the shares and options to acquire shares of the common stock of Rexahn Pharmaceuticals, Inc. (\"Rexahn\") on November 5, 2020, in exchange for shares and options to acquire shares of the common stock of Ocuphire Pharma, Inc. (\"Ocuphire\"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of June 17, 2020, as amended, between Rexahn, Razor Merger Sub, Inc., and Ocuphire pursuant to which Ocuphire became a wholly-owned subsidiary of Rexahn. Per the terms of the Merger Agreement, each share of Ocuphire common stock was converted into the right to receive 1.0565 shares of Rexahn common stock. Subsequent to the merger, the name of the issuer was changed from Rexahn Pharmaceuticals, Inc. to Ocuphire Pharma, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested."}],"balance_after":35663,"derivative":{"exercise_price":0.9,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":35663},"source":{"system":"sec-edgar","filing":"0001596771-20-000111","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000159677120000111/primary_doc.xml","form_type":"4"}},{"id":2988086,"issuer":{"id":5892,"kind":"organization","name":"Opus Genetics, Inc.","symbol":"IRD"},"owners":[{"id":51609,"kind":"person","name":"Ainsworth Sean","position":1,"cik":"0001830296","reported_name":"Ainsworth Sean","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-09T23:08:57.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":35800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired the shares and options to acquire shares of the common stock of Rexahn Pharmaceuticals, Inc. (\"Rexahn\") on November 5, 2020, in exchange for shares and options to acquire shares of the common stock of Ocuphire Pharma, Inc. (\"Ocuphire\"), pursuant to the Agreement and Plan of Merger and Reorganization, dated as of June 17, 2020, as amended, between Rexahn, Razor Merger Sub, Inc., and Ocuphire pursuant to which Ocuphire became a wholly-owned subsidiary of Rexahn. Per the terms of the Merger Agreement, each share of Ocuphire common stock was converted into the right to receive 1.0565 shares of Rexahn common stock. Subsequent to the merger, the name of the issuer was changed from Rexahn Pharmaceuticals, Inc. to Ocuphire Pharma, Inc."}],"balance_after":35800,"source":{"system":"sec-edgar","filing":"0001596771-20-000111","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1228627/000159677120000111/primary_doc.xml","form_type":"4"}}]}